In this issue of the Journal of the American Geriatrics Society (JAGS), the journal in collaboration with the Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) team introduces a new series called “Around the EQUATOR with Clin-STAR”.1 The objective of this series is to highlight existing reporting standards while addressing transdisciplinary challenges that may arise when these standards are applied to research involving older participants.
During the first decade of JAGS, most manuscripts were single-authored narrative reviews. When original data were published, the research was usually observational, and the methods in the corresponding manuscript lacked important details and uniform reporting standards. For example, in 1953 Dr. Arkell Vaughn reported on a consecutive set of 100 vagotomy procedures for the treatment of gastrointestinal ulcerations, but the manuscript neglected to explicitly identify the study design as a case series, to report patients’ eligibility criteria or to contemplate potential sources of bias.2 That same year, Rafsky and colleagues reported on the effect of methium chloride for older adults with hypertension.3 Their study lacked a control group, and the manuscript did not include reproducible details about the outcomes assessment, subgroup considerations, or statistical analysis. More than twenty years later, epidemiologists were still raising concerns about the quality of research designs in prestigious medical journals based upon unjustifiably small sample sizes and haphazard descriptions of data collection.4 In fact, key information needed to fully evaluate and replicate published research was not included in hundreds of original reports over decades across multiple medical fields.5 One consequence of this challenge to scientific rigor was a perception that medical research remained irreparably disconnected from bedside care,6 leading to significant waste in research spending.7
Epidemiologists and journal editors began to coalesce around the concept that more structured scientific research reporting was needed across specialties.8 Initial counterarguments included that the “sterilization” of literary style would reduce readers’ interest in the scientific reporting and that consensus among investigators and journal editors about the most appropriate reporting framework could not be achieved.9 However, beginning with the Consolidated Standards of Reporting Trials (CONSORT) in 1996, standardized checklists for research reporting began to appear.10 At the present time, 535 different reporting guidelines are housed by the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network (https://www.equator-network.org/), including standards for observational research, diagnostic and prognostic studies, qualitative research, systematic reviews, quality improvement, economic evaluations, and clinical practice guidelines.11–18 Most reporting guidelines are available in non-English formats, and many have been updated over the years. Some reporting guidelines include “extensions” for subtypes of research or unique populations. For example, Standards for Studies of Diagnostic Test Accuracy in Dementia (STARDdem) recommendations for accuracy studies in persons living with dementia have been developed.19
In the years following the release of CONSORT, the thoroughness of randomized controlled trial reporting has steadily improved in general medical journals, but this trend for improvement was not observed in specialized journals, including those in the fields of Geriatrics and Pharmacology.20,21 CONSORT is not the only EQUATOR Network reporting standard associated with more thorough scientific reporting. Newer EQUATOR reporting standards such as Standards for Reporting of Diagnostic Accuracy Studies (STARD) are gradually demonstrating improvements in the transparency of research reporting.22,23 Enhanced attention to these standards by investigators and editorial boards could accelerate the acquisition of new knowledge and reduce the quantity or premature adoption of less useful research. For example, stricter adherence to other EQUATOR reporting standards such as the Recording of studies Conducted using Observational Routinely collected Data for Pharmacoepidemiology (RECORD-PE) may have reduced the proportion of COVID-19 research that was subsequently retracted.24,25
Although JAGS recommends that authors submitting manuscripts of original research should adhere to the appropriate EQUATOR Network reporting standard, most of the standards have not been adapted to account for the complex issues that often characterize research of older participants;26,27 nor has the overall value of adherence to these standards been conclusively demonstrated. In other disciplines, significant misunderstandings exist between and within editorial boards regarding the correct reporting standard to use and the most appropriate manner in which to adhere to individual EQUATOR reporting standard recommendations.28 Moreover, peer-reviewers for journals receive relatively little guidance about how to evaluate adherence to EQUATOR standards.29 The Clin-STAR “Around the EQUATOR” series is designed to pre-emptively address challenges that may arise across disciplines for authors, reviewers, and editors for incorporating and suitably evaluating individual reporting standards based on lessons learned from frontline clinical researchers in aging. This new series starts with a contribution by Carpenter and colleagues on EQUATOR reporting standards for Implementation Science research involving older participants.1 Additional potential topics for this series are provided in the Table, which is organized according to those standards that may be most relevant to JAGS authors. Suggestions are welcome, however, from readers about other EQUATOR standards that are particularly challenging for researchers in aging. We believe that this series will accelerate adherence to appropriate EQUATOR Network standards, while simultaneously providing a roadmap for those who develop the reporting standards to “geriatricize” them with robust exemplars and toolkits in the future.30,31
Table.
Potential Topics for the Around the EQUATOR with Clin-STAR Series
Funding:
National Institute of Health U24AG06534
Sponsor’s Role:
Clin-STAR is supported by U24AG06524. Dr. Gill is also supported by the Yale Claude D. Pepper Older Americans Independence Center (P30AG021342). The funders had no role in developing the content of this manuscript.
Footnotes
Conflict of Interest: CRC and TMG are on the Clinician-Scientists Transdisciplinary Aging Research Leadership Core. CRC also co-authored the EQUATOR Network StaRI reporting guidelines.
References
- 1.Carpenter CR, Southerland LT, Lucey BP, Prusaczyk B. Around the EQUATOR with clinician-scientists transdisciplinary aging research (Clin-STAR) principles: implementation science challenges and opportunities. J Am Geriatr Soc 2022. (in press). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Vaughn AM. Supradiaphragmatic vagotomy in the treatment of gastrointestinal ulceration; report of 100 consecutive cases. J Am Geriatr Soc 1953;1:395–401. [DOI] [PubMed] [Google Scholar]
- 3.Rafsky HA, Horonick A, Rafsky JC. Treatment of hypertension in elderly patients with methium chloride; preliminary report. J Am Geriatr Soc 1953;1:545–8. [DOI] [PubMed] [Google Scholar]
- 4.Fletcher RH, Fletcher SW. Clinical research in general medical journals: a 30-year perspective. N Engl J Med 1979;301:180–3. [DOI] [PubMed] [Google Scholar]
- 5.Altman DG, Moher D. Chapter 1: Importance of Transparent Reporting of Health Research. In: Moher D, Altman DG, Schulz KF, Simera I, Wager E, eds. Guidelines for Reporting Health Research: A User’s Manual. 1st ed. London UK: John Wiley & Sons; 2014:3–13. [Google Scholar]
- 6.Morris AH, Ioannidis JPA. Limitations of medical research and evidence at the patient-clinician encounter scale. Chest 2013;143:1127–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ioannidis JPA, Greenland S, Hlatky MA, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 2014;383:166–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Docherty M, Smith R The case for structuring the discussion of scientific papers. BMJ 1999;318:1224–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Doherty M Uniform structured formats for scientific communications--how far should we go? Ann Rheum Dis 1997;56:81–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637–9. [DOI] [PubMed] [Google Scholar]
- 11.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573–7. [DOI] [PubMed] [Google Scholar]
- 12.Bossuyt P, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 2015;162:55–63. [DOI] [PubMed] [Google Scholar]
- 14.Ogrinc G, Davies L, Goodmand D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0-Standards for Quality Improvement Reporting Excellence-Revised Publication Guidelines from a Detailed Consensus Process. J Am Coll Surg 2016;222:317–23. [DOI] [PubMed] [Google Scholar]
- 15.Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMJ 2022;376:e067975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349–57. [DOI] [PubMed] [Google Scholar]
- 17.Page MJ, McKenzie JE, Bossuyt P, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chen Y, Yang K, Marušic A, et al. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement. Ann Intern Med 2017;166:128–32. [DOI] [PubMed] [Google Scholar]
- 19.Noel-Storr AH, McCleery JM, Richard E, et al. Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative. Neurology 2014;83:364–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.To MJ, Jones J, Emara M, Jadad AR. Are reports of randomized controlled trials improving over time? A systematic review of 284 articles published in high-impact general and specialized medical journals. PLoS One 2013;8:e84779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mills E, Loke YK, Wu P, et al. Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol 2004;58:61–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wilczynski NL. Quality of reporting of diagnostic accuracy studies: no change since STARD statement publication--before-and-after study. Radiology 2008;248:817–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dilauro M, McInnes MDF, Korevaar DA, et al. Is There an Association between STARD Statement Adherence and Citation Rate? Radiology 2016;280:62–7. [DOI] [PubMed] [Google Scholar]
- 24.Langan SM, Schmidt SA, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ 2018;363:k3532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Benchimol EI, Moher D, Ehrenstein V, Langan SM. Retraction of COVID-19 Pharmacoepidemiology Research Could Have Been Avoided by Effective Use of Reporting Guidelines. Clin Epidemiol 2020;12:1403–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Van Ness PH, Charpentier PA, Ip EH, et al. Gerontologic biostatistics: the statistical challenges of clinical research with older study participants. J Am Geriatr Soc 2010;58:1386–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hardy SE, Allore H, Studenski SA. Missing data: a special challenge in aging research. J Am Geriatr Soc 2009;57:722–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Goldacre B, Drysdale H, Dale A, et al. COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time. Trials 2019;20:118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hirst A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS One 2012;7:e35621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Schulz KF, Moher D, Altman DG. Chapter 5: Ambiguities and Confusions Between Reporting and Conduct. In: Moher D, Altman DG, Schulz KF, Simera I, Wager E, eds. Guidelines for Reporting Health Research: A User’s Manual. 1st ed. London UK: John Wiley & Sons; 2014:41–7. [Google Scholar]
- 31.Roberts JL, Houle TT, Loder EW, Penzien DB, Turner DP, Rothrock JF. Chapter 29: Establishing a Coherent Reporting Guidelines Policy in Health Journals. In: Moher D, Altman DG, Schulz KF, Simera I, Wager E, eds. Guidelines for Reporting Health Research: A User’s Guide. 1st ed. London UK: John Wiley & Sons; 2014:309–17. [Google Scholar]